Abstract N6-methyladenosine (m6A) methylation regulates gene expression/protein by
influencing numerous aspects of mRNA metabolism and contributes to neuropsychiatric …

Abstract N6-methyladenosine (m 6 A) is one of the most abundant chemical modifications on
RNA and can affect the occurrence and development of diseases. Some studies have …

Epitranscriptomic modifications can affect every aspect of RNA biology, including stability,
transport, splicing, and translation, participate in global intracellular mRNA metabolism, and …

Objective Recent research has suggested that m6A modification takes on critical
significance to Neurodegeneration. As indicated by the genome-wide map of m6A mRNA …

Alzheimer's disease (AD) is a neurodegenerative disorder that affects 35 million people
worldwide. However, no potential therapeutics currently are available for AD because of the …

Changes in epitranscriptome with N6-methyladenine (m6A) modification could be involved
in the development of multiple diseases, which might be a prevalent modification of …

One of the most common RNA modifications found in the mammalian brain is N6-
methyladenosine (m6A) and this modification has been implicated in fine-tuning neuronal …

Recent studies have revealed that the RNA N 6-methyladenosine (m6A) modification plays
a critical role in a variety of biological processes and associated with multiple diseases …

Abstract N 6-Methyladenosine (m 6 A) methylation is the most abundant post-transcription
modification in eukaryotes and plays a vital role in many pathological conditions including …

N6-methyladenosine (m6A) is the most abundant methylation, existing in> 25% of human
mRNAs. Exciting recent discoveries indicate the close involvement of m6A in regulating …